Loading...
XASX
OIL
Market cap127mUSD
Oct 09, Last price  
0.16AUD
1D
-8.57%
1Q
3.23%
Jan 2017
166.67%
Name

Optiscan Imaging Ltd

Chart & performance

D1W1MN
XASX:OIL chart
P/E
—
P/S
372.28
EPS
—
Div yield, %
—
Shrs. gr., 5y
11.30%
Rev. gr., 5y
-12.79%
Revenues
449k
-87.95%
5,707,5361,840,6492,887,6261,233,7481,776,954381,7911,303,34584,67752,592309,6971,333,2632,967,3371,322,1441,190,712889,5261,013,0391,680,1801,155,6043,724,230448,769
Net income
-7m
L+10.68%
-2,139,481-4,984,340-6,413,370-1,650,79914,405-2,502,450-643,950-1,417,712-1,395,399-1,337,056-2,942,925-2,035,327-2,344,119-1,765,353-2,126,695-4,233,037-4,351,500-6,060,496-6,311,952-6,986,043
CFO
-7m
L+14.36%
-1,882,270-4,094,939-3,189,129-1,227,864-468,579-793,545-1,193,270-683,392-1,459,644-509,246-3,412,811-2,323,792-1,420,797-1,396,563-2,126,309-3,833,578-3,152,494-5,744,450-6,212,032-7,103,837

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Optiscan Imaging Limited specializes in the development and market introduction of confocal microscopy technology, applied across both clinical and pre-clinical settings in Australia, Germany, and other global regions. A notable offering is the FIVE2 (ViewnVivo) system, a compact confocal endomicroscope utilized for a broad range of research, including clinical, translational, and pre-clinical studies. Additionally, the company is actively developing the InVivage device, which is intended for use in cancer screening and surgical procedures. Established in 1994, Optiscan Imaging Limited maintains its headquarters in Mulgrave, Australia.

Key people

Robert Cooke
Non-Executive Chairman of the Board · since 2021
Camile Farah
Chief Executive Officer, Managing Director, Executive Director · since 2021
Darius Ooi
Chief Financial Officer · since 2025
Brendan Fafiani
Chief Operating Officer · since 2023
Elissa Hansen
Company Secretary · since 2025
Karen Borg
Non-Executive Director · since 2021
Sean Gardiner
Non-Executive Director · since 2022
Ron Song
Non-Executive Director · since 2021
URL
https://www.optiscan.com/
IPO date
Aug 08, 1997
Employees
8
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT